Dengue Vaccine
Systematic review of dengue vaccine efficacy
... The outcomes of interest were primarily related to the efficacy of the dengue vaccine in preventing symptom- atic dengue and, secondarily, those linked to specific prevention of each of the four ...
8
“Construction of Envelope Domain III Based Recombinant Tetravalent Dengue Vaccine” by Ajit Kulkarni, Vikrant Sangar, Sweta Kothari, Shraddha Mehta, Ritwik Dahake, Sandeepan Mukherjee, Abhay Chowdhary, Ranjana A. Deshmukh, India.
... self-limited dengue fever (DF) or even life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome ...be dengue endemic. The development of dengue tetravalent ...
6
Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4
... classic dengue fever (DF) to dengue hemorrhagic fever (DHF) or dengue shock syndrome ...human dengue virus ...of dengue virus infection and for evaluating candidate formulations of ...
17
The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study
... higher dengue knowledge score and those with better vaccination attitude were more likely to accept the ...of dengue vaccination against the risk of den- gue ...income, dengue prevention practice, ...
10
A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
... vector-based vaccine will make subsequent vaccinations inef- ...(HIV) vaccine in nonhuman primates, preexisting immu- nity could be overcome by the use of a higher dose of ...HIV vaccine has been ...
8
Knowledge, acceptance and willingness to pay for Dengue vaccine in Yogyakarta and Jakarta
... prevent dengue infection and decrease the number of DHF ...of dengue vaccination as a new prevention strategy in Indonesia ...and dengue vaccination are proven to be more effective than a single ...
9
Descriptive Review of Safety, Reactogenicity and Immunogenicity of Dengue Vaccine Clinical Trials, 2003 – 2013
... a dengue vaccine has been one of the strategies employed to reduce the incidence of dengue worldwide together with other horizontal interventions such as vector control and the transgenic mosquito ...
9
Development of improved dengue 2 antigen configurations for a Venezuelan equine encephalitis virus replicon particle-launched dengue vaccine
... Employing a non-propagating Venezuelan equine encephalitis virus (VEE) replicon particle (VRP) system as a delivery system provides a way to circumvent the complications associated with dengue vaccine ...
84
Analysis of the optimal vaccination age for Dengue in Brazil with a tetravalent Dengue vaccine
... potential Dengue vaccine may have, or to find a cost-effective vaccination ...one Dengue serotypes in endemic areas resulting in the possibility of consecutive, heterologous infec- ...i.e. ...
46
Human antibody response to dengue virus: implications for dengue vaccine design
... DENV vaccine design Currently, there are no licensed dengue vaccine which are used ...clinically. Dengue vaccine research has been carried out for the past 70 years, beginning with the ...
6
Feasibility and willingness to pay for dengue vaccine in the threat of dengue fever outbreaks in Vietnam
... the dengue vaccine, particularly among travelers, resulting in acceptance and WTP of the commu- nity for the ...and vaccine manufactures knowledge of people’s perception of dengue vaccines in ...
10
An economic evaluation of vector control in the age of a dengue vaccine
... a dengue vaccine did not preclude efforts to model the condi- tions under which such an immunization strategy might be cost-effective ...first-ever dengue vaccine, known as chimeric yellow ...
27
The Human CD8+ T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes
... the vaccine strains were predicted for their binding affinity to 27 major histocompatibility com- plex (MHC) class I ...the vaccine serotype they are derived from (see Table S2 in the supplemental ...
9
Chimeric Yellow Fever/Dengue Virus as a Candidate Dengue Vaccine: Quantitation of the Dengue Virus-Specific CD8 T-Cell Response
... virus vaccine, given the association between cross-reactive, nonneutralizing antibodies and ...the vaccine induces protective immunity against one DEN virus serotype but primes the immunized individual for ...
8
Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus Serotypes
... in dengue-infested regions with about 100 million new cases each year, although many of these infections are believed to be ...of dengue virus; thus, immunity from one serotype will not cross-protect from ...
8
Dengue fever: Causes, complications, and vaccine strategies – A review
... severe dengue disease is a multifactorial process in which the presence of preexisting heterologous antibodies plays an important ...DENV vaccine, lack of an adequate animal disease model, and immune ...
7
A NOVEL TETRAVALENT RECOMBINANT ENVELOPE DOMAIN III VACCINE AGAINST DENGUE: AN IN SILICO APPROACH
... effective dengue vaccine is a challenging task and has been hampered mainly because of the concern that cross reactive immunological memory elicited by a vaccine candidate could increase the risk of ...
10
Recent Advances in Vaccine Development for the Treatment of Emerging Infectious Diseases
... Pasteur Dengue Vaccine The Sanofi Pasteur tetravalent Dengue vaccine is a recombinant live attenuated ...fever vaccine (YFV 17D) replica- tion genes and integrates the envelope genes of ...
12
Multi-walled carbon nanotubes increase antibody-producing B cells in mice immunized with a tetravalent vaccine candidate for dengue virus
... of dengue is symptomatic as no specific antiviral drugs are available, therefore, the WHO con- siders the establishment of an effective vaccine against these viruses a ...ideal dengue vaccine ...
12
nihms966360.pdf
... about vaccine- induced immune enhancement as seen in natural infection ...first dengue vaccine represented a major milestone, there have also been ...three vaccine doses were given separated ...
16